PPAR regulates transcription of a set of genes containing the peroxisome proliferator response elements, which are involved in the mitochondrial and peroxisomal -oxidation, transport, and export of fatty acids [28, 29]
But dig deeper into the clinical data, the receptor pharmacology, and the real-world side effect profiles, and these two treatments diverge in ways that matter enormously for researchers trying to decide between them
A 2024 review in Cartilage identified AOD-9604 among key peptides recognized for benefits to bone and joint health, noting its capacity for chondrogenic induction and cartilage regeneration in osteoarthritis models
The three Treatment Tables below all include the same therapies, each organized a different way: Sorted by Therapy Sorted by Primary Intended Outcome Sorted by Therapy Category Additional information included in the Treatments Tables: Secondary Intended Outcomes, Relative Costs, Costs Breakdown, and Support needed after initial instruction from/consultation with an HCP
Research indicates the peptide crosses the blood-brain barrier, potentially offering neuroprotective benefits (Sikiric et al., Current Pharmaceutical Design, 2020)